Cargando…

Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins

It is believed that a subset of primary ovarian mucinous tumors is derived from mature teratomas [1–5]. To confirm this, we performed microsatellite genotyping using a variety of short tandem repeat makers and analyzed allelotypes of 8 mucinous tumors (4 mucinous carcinomas, 3 atypical proliferative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yihong, Shwartz, Lauren Ende, Anderson, Derek, Lin, Ming-Tseh, Haley, Lisa, Wu, Ren-chin, Vang, Russell, Shih, Ie-ming, Kurman, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673211/ https://www.ncbi.nlm.nih.gov/pubmed/26355245

Ejemplares similares

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
por: Gross, Amy L., et al.
Publicado: (2010)

Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions
por: Wu, Ren‐Chin, et al.
Publicado: (2019)

Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms
por: Cobb, Lauren Patterson, et al.
Publicado: (2015)

The molecular origin and taxonomy of mucinous ovarian carcinoma
por: Cheasley, Dane, et al.
Publicado: (2019)

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
por: Sehdev, Ann Smith, et al.
Publicado: (2010)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2019)

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2021)

Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
por: Yehya, Misbah, et al.
Publicado: (2019)

Large intra-abdominal mucinous cystic adenoma: is it of ovarian or mesenteric origin
por: Lambert, Radisnay Guzmán, et al.
Publicado: (2020)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors
por: Liew, Phui‐Ly, et al.
Publicado: (2018)

CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous Carcinoma
por: Kuhn, Elisabetta, et al.
Publicado: (2016)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark
por: Hannibal, Charlotte G., et al.
Publicado: (2022)

Follicular fluid has more to offer: Insulin-like growth factor axis on ovarian carcinogenesis
por: Chu, Tiffany, et al.
Publicado: (2019)

Re: Article by Natalie Banet and Robert J. Kurman: Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis; Int. J. Gynecol. Pathol. 2015;34:3–8
por: Kurman, Robert J., et al.
Publicado: (2015)

Mucinous Borderline Tumor Associated with Mesonephric-like Proliferation: Further Evidence for a Possible New Origin of Ovarian Mucinous Neoplasms
por: Zhang, Jie, et al.
Publicado: (2022)

A Recurrent Mucinous Neoplasm Originating From an Ovarian Mucinous Cystadenoma After an Adnexectomy As the First Procedure: A Case Report
por: Ohira, Satoshi, et al.
Publicado: (2022)

Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer
por: Fu, Fengxian, et al.
Publicado: (2021)

The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012)

Diagnostic potential of tumor DNA from ovarian cyst fluid
por: Wang, Yuxuan, et al.
Publicado: (2016)

Lack of a Y-Chromosomal Complement in the Majority of Gestational Trophoblastic Neoplasms
por: Yap, Kai Lee, et al.
Publicado: (2010)

Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment
por: Wang, Yicong, et al.
Publicado: (2023)

DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression
por: Kshirsagar, Malti, et al.
Publicado: (2012)

Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms
por: Lee, Yi-Ju, et al.
Publicado: (2016)

Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma
por: Taguchi, Ayumi, et al.
Publicado: (2022)

Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors
por: Hasbay, Ebru, et al.
Publicado: (2023)

Borderline mucinous cystic ovarian tumor with mural nodules (carcinosarcoma)
por: Chang, Juei-Shan, et al.
Publicado: (2012)

Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer
por: Jung, Jin-Gyoung, et al.
Publicado: (2014)

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
por: McAlpine, Jessica N, et al.
Publicado: (2009)

In vivo and in vitro Propagation of Intraductal Papillary Mucinous Neoplasms
por: Kamiyama, Hirohiko, et al.
Publicado: (2010)

Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma
por: He, Xiaoli, et al.
Publicado: (2023)

The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
por: Chang, Kuang-Leei, et al.
Publicado: (2016)

Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
por: Jones, Tiffany Nicole, et al.
Publicado: (2023)

Intestinal Antigenicity of Ovarian Mucinous Cystadenomas
por: Nairn, R. C., et al.
Publicado: (1971)

Mucins in ovarian cancer diagnosis and therapy
por: Chauhan, Subhash C, et al.
Publicado: (2009)

Recent Insights into Mucinous Ovarian Carcinoma
por: Ricci, Francesca, et al.
Publicado: (2018)

Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)

Profiling the immune landscape in mucinous ovarian carcinoma
por: Meagher, Nicola S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qa4t68mrvsrft0jaqc787luus2